Endogenous Intact PTH is Suppressed during Teriparatide (rhPTH 1-34) Administration in Postmenopausal Women with Established Osteoporosis

Introduction: Teriparatide (recombinant human PTH 1-34/TPTD) is an osteoanabolic agent available for osteoporosis treatment. The aim of this prospective trial was to evaluate the acute and chronic effects of TPTD in endogenous intact PTH (iPTH) levels in postmenopausal women with established osteopo...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Endocrine Journal 2008, Vol.55(3), pp.613-616
Hauptverfasser:	ANASTASILAKIS, Athanasios D., POLYZOS, Stergios A., GOULIS, Dimitrios G., SLAVAKIS, Aristides, EFSTATHIADOU, Zoe, KITA, Marina, KOUKOULIS, George, AVRAMIDIS, Avraam
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Alkaline Phosphatase - blood Bone Density Bone Density Conservation Agents - therapeutic use Calcium - blood Female Follow-Up Studies Humans Osteoporosis treatment Osteoporosis, Postmenopausal - blood Osteoporosis, Postmenopausal - drug therapy Parathyroid hormone Parathyroid Hormone - blood Phosphorus - blood Teriparatide Teriparatide - administration & dosage Teriparatide - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!